Peter Hoglund - Royce Value Treasurer
| RVT Stock | USD 16.23 0.30 1.88% |
Executive
Mr. Peter K. Hoglund serves as Treasurer of the company. He is Chief Financial Officer, Chief Administrative Officer, and Managing Director of RA, having been employed by RA since December 2014. Prior to joining RA, Mr. Hoglund spent more than 20 years with Munder Capital Management in Birmingham, MI, serving as Managing Director and Chief Financial Officer and overseeing all financial aspects of the firm. since 2015.
| Age | 54 |
| Tenure | 9 years |
| Address | 745 Fifth Avenue, New York, NY, United States, 10151 |
| Phone | 212 508 4500 |
| Web | https://www.roycefunds.com/funds/royce-value-trust |
Royce Value Management Efficiency
At this time, Royce Value's Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 0.18 in 2024, whereas Return On Tangible Assets are likely to drop 0.17 in 2024. Non Current Liabilities Total is likely to gain to about 45.2 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 21.2 M in 2024. Royce Value's management efficiency ratios could be used to measure how well Royce Value manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Michael Holland | Reaves Utility If | 75 | |
| Theron Hoffman | John Hancock Financial | 72 | |
| Marianne Harrison | John Hancock Financial | 57 | |
| James Jacobson | Allianzgi Diversified Income | 75 | |
| Laura Woodward | Tekla Healthcare Opportunities | 51 | |
| Dana Devivo | Cohen Steers Total | 39 | |
| Charles Bardelis | John Hancock Financial | 79 | |
| Jay Fife | BlackRock Science Tech | 51 | |
| Larry Papasan | Reaves Utility If | 79 | |
| Lucinda Stebbins | Tekla Life Sciences | 73 | |
| Martin Wolin | MFS Investment Grade | 52 | |
| DawnMarie Driscoll | DWS Municipal Income | 74 | |
| Francis Knox | John Hancock Financial | 73 | |
| Bradford Gallagher | Allianzgi Diversified Income | 75 | |
| William Reardon | Tekla Life Sciences | 74 | |
| Richard Herring | DWS Municipal Income | 74 | |
| Thomas Faust | Eaton Vance Tax | 63 | |
| Lisa Phelan | Cohen Steers Reit | 51 | |
| Matthew Stowe | MFS Investment Grade | 45 | |
| Theodore Uhl | Reaves Utility If | 45 | |
| Deborah DeCotis | Allianzgi Diversified Income | 69 | |
Management Performance
| Return On Equity | 0.12 | ||||
| Return On Asset | -3.0E-4 |
Royce Value Closed Leadership Team
Elected by the shareholders, the Royce Value's board of directors comprises two types of representatives: Royce Value inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Royce. The board's role is to monitor Royce Value's management team and ensure that shareholders' interests are well served. Royce Value's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Royce Value's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Hoglund, Treasurer | ||
| Charles Royce, President, Primary Portfolio Manager and Interested Director | ||
| Arthur Mehlman, Independent Director | ||
| Lisa Curcio, Chief Compliance Officer | ||
| Stephen Isaacs, Independent Director | ||
| David Meister, Independent Director | ||
| G OBrien, Independent Director | ||
| Francis Gannon, Vice President | ||
| John Denneen, Chief Legal Officer and Secretary | ||
| Cecile Harper, Independent Director | ||
| Daniel OByrne, Vice President | ||
| Michael Shields, Independent Director | ||
| Christopher Grisanti, Independent Director | ||
| Christopher Flynn, Portfolio Manager | ||
| Christopher Clark, President, Chief Executive Officer, Co-Chief Investment Officer, Managing Director | ||
| Lauren CFA, Principal Manager | ||
| Patricia Chadwick, Independent Director |
Royce Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Royce Value a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | ||||
| Return On Asset | -3.0E-4 | ||||
| Profit Margin | 9.94 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 1.91 B | ||||
| Shares Outstanding | 115.35 M | ||||
| Shares Owned By Insiders | 0.06 % | ||||
| Shares Owned By Institutions | 27.43 % | ||||
| Number Of Shares Shorted | 32.42 K | ||||
| Price To Earning | 4.66 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Royce Stock Analysis
When running Royce Value's price analysis, check to measure Royce Value's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royce Value is operating at the current time. Most of Royce Value's value examination focuses on studying past and present price action to predict the probability of Royce Value's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royce Value's price. Additionally, you may evaluate how the addition of Royce Value to your portfolios can decrease your overall portfolio volatility.